The Meningococcal Groups A,c,y,and W, cataloged under National Stock Number 6505-01-582-5875, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxosmithkline, Llc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-582-5875 |
| Primary Part Number | NDC58160-0955-09 |
| Item Name | Meningococcal Groups A,c,y,and W |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxosmithkline, Llc |
| Status | ACTIVE |
| Storage Temp Range | +2.0 TO 8.0 CELSIUS DEGC |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NIMENRIX | Glaxosmithkline Pharmaceuticals (BEL) |
| 9319099002866 | Anspec Pty Ltd (AUS) |
| NDC58160-0955-09 PRIMARY | Glaxosmithkline, Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM104263 | 5/1 Secondary reference Defense Medical Standardization Board |
| 15879 | 5/1 Secondary reference U.S. Government activity |
| 2950996 | 6/9 Informative reference only Association Pharmaceutique Belge-Algemene Pharmaceutische Bond |
NSN 6505-01-582-5875 is a Meningococcal Groups A,c,y,and W, manufactured by Glaxosmithkline, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-582-5875 has 3 manufacturer part numbers on file: NIMENRIX (Glaxosmithkline Pharmaceuticals), 9319099002866 (Anspec Pty Ltd), NDC58160-0955-09 (Glaxosmithkline, Llc).
Key specifications for NDC58160-0955-09: Storage Temp Range: +2.0 TO 8.0 CELSIUS DEGC; Special Features: 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 2-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT DEGC; Part Name Assigned by Controlling Agency: MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.